Clinical Trials Directory

Trials / Completed

CompletedNCT06033755

Managing Dysfunctional Breathing and Exercise-induced Laryngeal Obstruction in Adolescent Athletes

A Multidimensional Strategy to Managing Dysfunctional Breathing and Exercise-induced Laryngeal Obstruction in Adolescent Athletes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
18 (actual)
Sponsor
VID Specialized University · Academic / Other
Sex
All
Age
13 Years – 19 Years
Healthy volunteers
Not accepted

Summary

This study aimed to assess if a multidimensional individually tailored intervention, including Norwegian Psychomotor Physiotherapy (NPMP), elements of cognitive behavioural therapy and a rehabilitation plan, helped reduce inspiratory distress and dysfunctional breathing in adolescent athletes with EILO. A mixed methods design, which combined qualitative and quantitative research, was used. Data, including subjective experiences of respiratory distress, findings from NPMP body examinations and objective measurements of lung function and aerobic capacity were gathered before and after a five month intervention involving 18 participants.

Conditions

Interventions

TypeNameDescription
OTHERNorwegian psychomotor physiotherapyThe intervention consisted predominantly of Norwegian Psychomotor Physiotherapy (NPMP) in which participants received individually tailored treatment based on the body examination and reported respiratory distress. NPMP addresses bodily tension, postural de-alignments and dysfunctional breathing patterns. The consultations also included a cognitive dimension, that is a conversation, in which thoughts and behaviours about training and competing were addressed and where participants were provided with "self help" measures that could improve breathing during training and competing. A rehabilitation plan for each participant was designed to limit further impairments and maintaining aerobic capacity without intensifying EILO symptoms. The intervention lasted 5 months.

Timeline

Start date
2018-12-10
Primary completion
2023-01-30
Completion
2023-01-30
First posted
2023-09-13
Last updated
2023-09-13

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT06033755. Inclusion in this directory is not an endorsement.